Archives
-
Ouabain: Designing Better Pump-Inhibition Assays
2026-08-17
Ouabain is a selective Na+/K+-ATPase inhibitor that can reveal how ion transport, calcium handling, and cell fate interact. This guide applies quantitative assay principles from cancer-biology research to improve interpretation of ouabain experiments in cellular and cardiovascular models.
-
25-Hydroxycholesterol Reprograms Tumor Macrophages
2026-08-17
Xiao et al. identify CH25H-derived 25-hydroxycholesterol as an immunometabolic checkpoint that activates lysosomal AMPKα and reinforces STAT6-dependent immunosuppressive macrophage programming. The study connects lipid handling, macrophage metabolism, and T-cell exclusion, while showing that CH25H targeting can improve antitumor responses with or without PD-1 blockade.
-
Luminescent ATP Detection Assay Kit: Evidence & Use
2026-08-16
The Luminescent ATP Detection Assay Kit is a firefly luciferase ATP assay for ATP measurement in solutions, cells, and tissue samples. Product information reports a 1 nM–10 μM working range, a luminescent signal lasting up to 30 minutes, and lysis conditions compatible with downstream protein workflows.
-
HyperScribe™ Poly (A) Tailing Kit Workflow
2026-08-15
Build more consistent capped, polyadenylated RNA for transfection experiments and micro-injection workflows with a defined E-PAP-based reaction. This guide connects tail-length control, RNA quality checks, and assay design to studies of translation and mitochondrial metabolism.
-
tiRNA: Controllable Gene Silencing by Translation Inhibition
2026-08-14
The reference study introduces tiRNA, an aptamer-linked steric-blocking RNA that suppresses translation by targeting the 5′ UTR of a selected mRNA rather than degrading the transcript. Its reported siRNA-comparable activity and neutralizing-strand reversibility position tiRNA as a controllable platform for regulating protein expression, while also highlighting unresolved design and delivery challenges.
-
BIBP 3226 Trifluoroacetate: From Pathway to Proof
2026-08-14
BIBP 3226 trifluoroacetate enables receptor-level testing of NPY/NPFF signaling in adipose-neural cardiac models. This article translates recent arrhythmia findings into practical assay design, controls, and interpretation strategies.
-
Direct Mouse Genotyping Kit: Practical PCR Workflow
2026-08-13
The Direct Mouse Genotyping Kit K1025 simplifies routine mouse genetic screening by combining tissue lysis, balancing reagents, Proteinase K, and a dye-containing PCR master mix for direct amplification. It is intended for PCR-based genotyping and high-throughput workflows, not applications that require highly purified DNA or extensive downstream molecular analysis.
-
XXLP Regulates the NOX2–ROS Axis in Colitis
2026-08-13
The 2026 reference study connects Xu Chunfu’s Modified Xianglian Pill (XXLP) with coordinated regulation of the NOX2/ROS/mitochondria/NLRP3 axis and gut microbial imbalance in experimental ulcerative colitis. Its integrated chemical, animal, cellular, proteomic, imaging, and microbiome analyses provide a mechanistic framework for interpreting the formula’s anti-inflammatory activity while also defining important limits for clinical translation.
-
SU 5402: RTK Inhibitor Mechanism and Uses
2026-08-12
SU 5402, also called SU-5402, is a small-molecule receptor tyrosine kinase inhibitor with reported activity against VEGFR2, FGFR1, and PDGFRβ. Its strongest research uses include cancer biology, multiple myeloma research, signaling assays, apoptosis assay design, and cell cycle arrest studies.
-
Acid-Responsive Additives Improve RNA-LNP Transfection
2026-08-12
Cheung, Fuchs, and Shoichet developed acid-responsive polymer additives that promote RNA release from lipid nanoparticles after endosomal escape, rather than attempting to increase escape itself. Across established LNP formulations, the hybrid particles improved siRNA potency and mRNA transfection, supporting RNA–carrier dissociation as an underused determinant of cytosolic delivery.
-
Mechanical Stress, Cytoskeleton, and Autophagy
2026-08-11
The reference study provides direct evidence that compression-induced autophagy depends primarily on cytoskeletal microfilaments, while microtubules make a supporting contribution. Its force–time optimization and combined fluorescence, immunoblotting, and cytoskeletal perturbation strategy offer a useful framework for studying mechanotransduction without assuming that all cytoskeletal components play equivalent roles.
-
Trelagliptin Succinate: From DPP-4 to RUNX2
2026-08-11
Trelagliptin succinate, also known as SYR-472 succinate, offers translational researchers a way to connect selective DPP-4 enzyme inhibition with glucose-dependent insulin secretion and emerging bone biology. This article examines the AMPK–RUNX2 evidence, experimental design considerations, competitive positioning, and the limits of extending diabetes findings into osteoporosis research.
-
ATP Solution for mRNA and Kinase Workflows
2026-08-10
A ready-to-use 100 mM ATP reagent can improve control across transcription, kinase, ligation, and phosphorylation workflows. This practical guide connects ATP-dependent assay design with emerging p21 mRNA–LNP research while emphasizing reproducibility, contamination control, and troubleshooting.
-
Ciprofloxacin–Tetracycline Antagonism at Single-Cell Scale
2026-08-09
Broughton, Fraisse, and El Karoui used microfluidic single-cell analysis to show that ciprofloxacin–tetracycline antagonism is driven mainly by increased survival under the combination, rather than by a simple reduction in growth inhibition. Nutrient-dependent growth history and heterogeneous SOS-response states explain why the interaction is stronger in nutrient-rich conditions, providing a mechanistic framework for interpreting antibiotic combinations.
-
Triiodothyronine T3 Workflows for Cell Assays
2026-08-08
Use Triiodothyronine (T3) as a controlled thyroid-receptor perturbation to connect gene-expression, metabolic, and differentiation readouts. This practical workflow also explains how T3 can be positioned alongside spatially concentrated base-editing studies without confusing pathway modulation with genetic correction.